ClinicalTrials.Veeva

Menu

The Becoming of Children With Doose Syndrome (DOOSE)

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

Learning Disabilities
Doose Syndrome
Epileptic Syndromes

Treatments

Other: questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT04048213
PI2018_843_0058

Details and patient eligibility

About

Doose syndrome is a rare epileptic syndrome that can lead to learning difficulties and a poor quality of life. The goal of this study is to evaluate the evolution of epilepsy and its consequences on cognitive development and learning issues in children with Doose syndrome.

Full description

Doose syndrome is a rare epileptic syndrome beginning between ages two and five, characterized by myoclonic-astatic seizures which can be associated with myoclonic seizures, astatic seizures, absences and generalized tonic-clonic seizures. These seizures can be difficult to treat effectively and may lead to learning difficulties. During this study, parents of children with Doose syndrome will receive a questionnaire regarding learning disabilities, quality of life and epilepsy of their children.

Enrollment

50 estimated patients

Sex

All

Ages

1 to 6 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • children with doose syndrome diagnosed between ages 1 and 6
  • normal development until onset of seizures

Exclusion criteria

  • unconfirmed diagnoses
  • abnormal diagnoses
  • abnormal psychomotor development before onset of seizures
  • cerebral MRI abnormalities
  • other child epileptic syndromes

Trial contacts and locations

1

Loading...

Central trial contact

Patrick Berquin, Pr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems